Generic dossier
Oxybutynin
2.5 mg/mL, 5 mg/mL · Oral solution · Antispasmodic
Product data
- Strength
- 2.5 mg/mL, 5 mg/mL
- Dosage form
- Oral solution
- Dosage-form group
- Oral liquid
- Therapeutic area
- Antispasmodic
- Market
- EU/US
- Status
- Partner sought for dossier completion
- Development status
- Ready for technology transfer
- Portfolio
- Generic dossier
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23